Detalles de la búsqueda
1.
Prolonged postoperative hypoaldosteronism related to hyperkalemia in patients with aldosterone-producing adenoma.
Endocr J
; 70(9): 917-924, 2023 Sep 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-37423737
2.
Prediction of unilateral hyperaldosteronism on adrenal vein sampling using captopril challenge test in patients with primary aldosteronism.
Endocr J
; 68(1): 45-51, 2021 Jan 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-32848105
3.
A head-to-toe dimerization has physiological relevance for ligand-induced inactivation of protein tyrosine receptor type Z.
J Biol Chem
; 294(41): 14953-14965, 2019 10 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-31416834
4.
Favourable effect of the sodium-glucose co-transporter-2 inhibitor canagliflozin plus the dipeptidyl peptidase-4 inhibitor teneligliptin in combination on glycaemic fluctuation: An open-label, prospective, randomized, parallel-group comparison trial (the CALMER study).
Diabetes Obes Metab
; 22(3): 458-462, 2020 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-31486230
5.
Discovery and structure-activity relationship of imidazolinylindole derivatives as kallikrein 7 inhibitors.
Bioorg Med Chem Lett
; 29(2): 334-338, 2019 01 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-30522951
6.
Structure-based design, synthesis, and binding mode analysis of novel and potent chymase inhibitors.
Bioorg Med Chem Lett
; 28(2): 188-192, 2018 01 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-29191554
7.
Structure-based drug design of 1,3,6-trisubstituted 1,4-diazepan-7-ones as selective human kallikrein 7 inhibitors.
Bioorg Med Chem Lett
; 28(8): 1371-1375, 2018 05 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29550094
8.
Structure-based drug design to overcome species differences in kallikrein 7 inhibition of 1,3,6-trisubstituted 1,4-diazepan-7-ones.
Bioorg Med Chem
; 26(12): 3639-3653, 2018 07 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-29884582
9.
Discovery and structure-activity relationship study of 1,3,6-trisubstituted 1,4-diazepane-7-ones as novel human kallikrein 7 inhibitors.
Bioorg Med Chem Lett
; 27(23): 5272-5276, 2017 12 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29102227
10.
Ipragliflozin effectively reduced visceral fat in Japanese patients with type 2 diabetes under adequate diet therapy.
Endocr J
; 63(6): 589-96, 2016 Jun 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-27052123
11.
Discovery of novel series of 6-benzyl substituted 4-aminocarbonyl-1,4-diazepane-2,5-diones as human chymase inhibitors using structure-based drug design.
Bioorg Med Chem
; 21(14): 4233-49, 2013 Jul 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-23719288
12.
A case of subacute thyroiditis after influenza vaccination.
Endocrinol Diabetes Metab Case Rep
; 2023(1)2023 Jan 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37931407
13.
Subacute thyroiditis associated with thyrotoxic periodic paralysis after COVID-19 vaccination: a case report.
Endocrinol Diabetes Metab Case Rep
; 20222022 May 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35578985
14.
Structural insight into the reaction mechanism and evolution of cytokinin biosynthesis.
Proc Natl Acad Sci U S A
; 105(7): 2734-9, 2008 Feb 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-18258747
15.
Impact of endogenous insulin secretion on the improvement of glucose variability in Japanese patients with type 2 diabetes treated with canagliflozin plus teneligliptin.
J Diabetes Investig
; 12(8): 1395-1399, 2021 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-33325645
16.
Improved time in range and postprandial hyperglycemia with canagliflozin in combination with teneligliptin: Secondary analyses of the CALMER study.
J Diabetes Investig
; 12(8): 1417-1424, 2021 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-33421309
17.
Initial dip predicts renal protective effects after the administration of sodium-glucose cotransporter 2 inhibitors in patients with type 2 diabetes and chronic kidney disease with normoalbuminuria.
J Clin Transl Endocrinol
; 22: 100244, 2020 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-33318949
18.
A randomized controlled trial comparing the effects of dapagliflozin and DPP-4 inhibitors on glucose variability and metabolic parameters in patients with type 2 diabetes mellitus on insulin.
Diabetol Metab Syndr
; 9: 54, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-28725273
19.
Targeting PTPRZ inhibits stem cell-like properties and tumorigenicity in glioblastoma cells.
Sci Rep
; 7(1): 5609, 2017 07 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-28717188
20.
Small-molecule inhibition of PTPRZ reduces tumor growth in a rat model of glioblastoma.
Sci Rep
; 6: 20473, 2016 Feb 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-26857455